PsyAccess
Am I eligible?
Am I eligible?
Clinical trialsRegistry-verifiedHospital-route model

AP-HM — Hôpital de la Conception (Centre Hospitalier Régional de Marseille)

Marseille, France

Treatment & access

  • Treatments offeredLSD (MM120 — clinical trial)
  • Access routeTrial
  • Cost & coverage (registry status)Free within clinical trial
  • Websitehttps://www.ap-hm.fr

About this provider

Compiled from the registry data on this page.

The Panorama study, a Phase 3 clinical trial of MM120 (lysergide, a pharmaceutical form of LSD) in generalized anxiety disorder, lists AP-HM — Hôpital de la Conception (Centre Hospitalier Régional de Marseille) in Marseille, France, among its sites. The trial is registered on ClinicalTrials.gov under NCT06809595, the registry source cited by this record. As of 2026-08-07 the registry status is ACTIVE_NOT_RECRUITING: recruitment has closed, so this site is not accepting new participants. For enrolled participants, treatment within the trial is free of charge. The record was last verified on 2026-08-07.

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Clinical trials access in France follows published criteria. A short pre-screening comes first — then your compiled summary goes to AP-HM — Hôpital de la Conception (Centre Hospitalier Régional de Marseille) only with your explicit consent, and you can download it for yourself either way.

Check my fit & enquire

About two minutes. The check itself runs in your browser — your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.

Check my fit & enquire